Opus Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Opus Investment Management's BMY Position: Q1 2020 in Review
Opus Investment Management sold out of Bristol-Myers Squibb (BMY) in Q1 2020, closing a stake of 55,700 shares — an estimated $3.58M sold.
Opus Investment Management first reported a position in BMY in Q2 2013 and held it in 25 quarters. The position peaked at $4.3M in Q3 2013. 2,149 funds tracked by Wall St. Rank hold BMY as of Q1 2020.
- Opus Investment Management reported no remaining Bristol-Myers Squibb position as of Q1 2020 after selling out during the quarter.
- Opus Investment Management sold 55,700 Bristol-Myers Squibb shares in Q1 2020, an estimated $3.58M.
- Opus Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 25 quarters.
- Opus Investment Management's Bristol-Myers Squibb position peaked at $4.3M in Q3 2013.
- 2,149 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2020.
Based on Opus Investment Management's 13F filing for Q1 2020, filed 14 May 2020.